![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2016
Hunzelmann, N.; Riemekasten, G.; Becker, M. O.; Moinzadeh, P.; Kreuter, A.; Melchers, I.; Mueller-Ladner, U.; Meier, F.; Worm, M.; Lee, H.; Herrgott, I.; Pfeiffer, C.; Fierlbeck, G.; Henes, J.; Juche, A.; Zeidler, G.; Mensing, H.; Günther, C.; Sárdy, M.; Burkhardt, H.; Koehm, M.; Kuhr, K.; Krieg, T. und Sunderkötter, C.
(2016):
The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.
In: British Journal of Dermatology, Bd. 174, Nr. 6: S. 1384-1387
2014
Moinzadeh, P.; Elisabeth, A.; Blank, N.; Distler, J.; Fierlbeck, G.; Genth, E.; Guenther, C.; Hein, R.; Henes, J.; Hellmich, M.; Herrgott, I.; Koetter, I.; Kreuter, A.; Krieg, T.; Melchers, I.; Mensing, H.; Mueller-Ladner, U.; Pfeiffer, C.; Riemekasten, G.; Sardy, M.; Susok, L.; Worm, M.; Wozel, G.; Zeidler, G.; Sunderkoetter, C.; Hunzelmann, N. und DNSS Ctr
(2014):
Analysis of REAL Life Vasoactive Therapy in over 3000 Patients with Systemic Sclerosis (SSC) Reveals Considerable Undertreatment and Significant Changes of Treatment Practice since 2004.
EULAR 2014, Paris, 11-14 June 2014.
Annals of the rheumatic diseases.
Bd. 73, Nr. Suppl. 2
BMJ Publishing Group. S. 564
[PDF, 62kB]
1989
Roedewald, H. R.; Koszinowski, Ulrich H.; Eichmann, K. und Melchers, I.
(1989):
Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld- restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
In: The Journal of Immunology, Bd. 143: S. 4238-4243
[PDF, 644kB]